J. Lok

发表

Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI.

J. Bussink, M. Schabel, K. Nicolay, 2018, Cancer research.

The potential of hyperpolarized 13C magnetic resonance spectroscopy to monitor the effect of combretastatin based vascular disrupting agents

J. Bussink, M. Horsman, H. Stødkilde-Jørgensen, 2017, Acta oncologica.

Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4

J. Bussink, J. Kaanders, A. J. van der Kogel, 2011, BMC Cancer.

Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parameters.

J. Bussink, A. Heerschap, C. Punt, 2004, International journal of radiation oncology, biology, physics.

Early Response Monitoring with 18F-FDG PET and Cetuximab-F(ab′)2-SPECT After Radiotherapy of Human Head and Neck Squamous Cell Carcinomas in a Mouse Model

J. Bussink, J. Kaanders, O. Boerman, 2014, The Journal of Nuclear Medicine.

Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells

B. Hoeben, J. Bussink, O. Boerman, 2022, Molecular pharmaceutics.

Preclinical validation of 111In-girentuximab-F(ab')2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts.

B. Hoeben, J. Bussink, E. Oosterwijk, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.

W. Oyen, J. Bussink, J. Kaanders, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumor Microenvironmental Changes Induced by the Sulfamate Carbonic Anhydrase IX Inhibitor S4 in a Laryngeal Tumor Model

J. Bussink, P. Span, C. Supuran, 2014, PloS one.

Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models

B. Hoeben, J. Bussink, O. Boerman, 2021, Physics and imaging in radiation oncology.

No detectable hypoxia in malignant salivary gland tumors: preliminary results.

P. D. de Wilde, J. Kaanders, A. J. van der Kogel, 2009, International journal of radiation oncology, biology, physics.

CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models

B. Hoeben, J. Bussink, V. Tolmachev, 2019, Scientific Reports.

Can 111In-RGD2 Monitor Response to Therapy in Head and Neck Tumor Xenografts?

W. Oyen, O. Boerman, G. Franssen, 2014, The Journal of Nuclear Medicine.

Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes

J. Bussink, B. Tops, P. Span, 2019, Thoracic cancer.

Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.

J. Kaanders, A. J. van der Kogel, H. Marres, 2009, European journal of cancer.

Carbogen breathing differentially enhances blood plasma volume and 5-fluorouracil uptake in two murine colon tumor models with a distinct vascular structure.

A. Heerschap, C. Punt, A. J. van der Kogel, 2006, Neoplasia.

Modulation of Hypoxia in Murine Liver Metastases of Colon Carcinoma by Nicotinamide and Carbogen

J. Bussink, A. Heerschap, C. Punt, 2005, Radiation research.

Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.

L. de Geus-Oei, J. Bussink, P. Span, 2012, Lung cancer.

Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas

A. Heerschap, C. Punt, A. Corti, 2006, Investigational New Drugs.

Expression of EGFR under tumor hypoxia: identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance.

J. Bussink, J. Kaanders, H. Marres, 2012, International journal of radiation oncology, biology, physics.

Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.

J. Bussink, P. Span, J. Kaanders, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Correlation of [18F]FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts

W. Oyen, J. Bussink, J. Kaanders, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Correlation of [18F]FMISO autoradiography and pimonidazole immunohistochemistry in human head and neck carcinoma xenografts

W. Oyen, J. Bussink, J. Kaanders, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.

A. Heerschap, T. Ruers, C. Punt, 2006, International journal of radiation oncology, biology, physics.

Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.

W. Oyen, L. de Geus-Oei, M. Rijpkema, 2005, Radiology.

Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI.

A. Heerschap, A. J. van der Kogel, G. Gambarota, 2006, Magnetic resonance imaging.

107 Comparison of 18F-MISO autoradiography with immunohistochemistry after modification of hypoxia in human glioma and squamous cell xenografts

J. Bussink, J. Kaanders, M. Philippens, 2006 .

106 Characterization of human squamous cell head and neck carcinoma xenografts using 18F-FLT and 18F-MISO autoradiography and immunohistochemistry

J. Bussink, J. Kaanders, M. Philippens, 2006 .

No detectable hypoxia in malignant salivary gland tumors: preliminary results.

P. D. de Wilde, J. Kaanders, A. J. van der Kogel, 2009, International journal of radiation oncology, biology, physics.